# The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

> **NCT04808648** · PHASE1 · UNKNOWN · sponsor: **Nanjing Sanhome Pharmaceutical, Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** SH-1028
- **DRUG:** Itraconazole
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT04808648
- **Lead sponsor:** Nanjing Sanhome Pharmaceutical, Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-06
- **Primary completion:** 2021-06-10
- **Final completion:** 2021-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808648, "The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04808648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*